Share Price and Basic Stock Data
Last Updated: November 10, 2025, 11:02 pm
| PEG Ratio | 0.00 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
Advance Petrochemicals Ltd operates within the Chemicals – Inorganic sector, reporting a stock price of ₹173 and a market capitalization of ₹15.5 Cr. The company displayed a notable revenue growth trajectory, with sales rising from ₹27.92 Cr in March 2022 to ₹37.09 Cr in March 2023. However, there was a slight decline in the subsequent fiscal year, with sales reported at ₹35.19 Cr in March 2024. The trailing twelve months (TTM) sales stood at ₹48.64 Cr, indicating a recovery in business performance. Quarterly sales figures illustrate fluctuations, with a peak of ₹15.16 Cr recorded in March 2025, affirming the company’s ability to capture market demand. The operating profit margin (OPM) has remained relatively low, averaging around 4.42%, which may reflect the competitive pricing pressures and cost structures prevalent in the chemicals industry.
Profitability and Efficiency Metrics
Profitability metrics reveal a mixed performance for Advance Petrochemicals Ltd. The net profit stood at ₹0.30 Cr for the fiscal year ending March 2025, with a net profit margin of 0.60%. The company reported a return on equity (ROE) of 7.71% and a return on capital employed (ROCE) of 9.56%, both of which are modest compared to industry standards. The operating profit for March 2025 was ₹1.51 Cr, with an operating profit margin (OPM) of 3.02%, indicating challenges in maintaining cost efficiency. The interest coverage ratio (ICR) stood at 2.26x, suggesting that the company can meet its interest obligations comfortably, yet it remains essential to monitor this as debt levels have increased. The cash conversion cycle (CCC) averaged 37.41 days, reflecting effective management of working capital, although a longer CCC could signal potential cash flow challenges.
Balance Sheet Strength and Financial Ratios
Advance Petrochemicals Ltd’s balance sheet shows a total borrowings figure of ₹10.85 Cr, with total liabilities reaching ₹25.34 Cr by March 2025. This results in a total debt-to-equity ratio of 2.69, indicating a high reliance on debt financing, which can be a concern in volatile markets. The company reported reserves of ₹3.14 Cr, which is a positive indicator of retained earnings that can support future growth. The book value per share stood at ₹44.86, while the price-to-book value (P/BV) ratio was 4.43x. This high P/BV ratio suggests that the market has high expectations for the company’s future growth. Additionally, the interest coverage ratio (ICR) of 2.26x indicates that while the company can cover its interest expenses, the margin is slim, which could limit its financial flexibility if cash flows tighten.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Advance Petrochemicals Ltd reveals that promoters hold 50.11% of the total shares, while the public holds 49.89%. This balanced distribution suggests a stable ownership structure. Over the past year, promoter holdings have fluctuated, dropping to 44.32% in June 2023 before recovering to the current level. This fluctuation may raise concerns about insider confidence among public investors. The total number of shareholders increased to 2,145 by March 2025, indicating growing investor interest. However, the absence of foreign institutional investors (FIIs) and domestic institutional investors (DIIs) could reflect a cautious stance from larger institutional players, potentially due to the company’s volatility in financial performance and modest profitability metrics.
Outlook, Risks, and Final Insight
Looking ahead, Advance Petrochemicals Ltd faces both opportunities and challenges. The company has demonstrated revenue growth potential, evidenced by the TTM sales of ₹48.64 Cr, but must address profitability concerns to enhance shareholder value. The high debt levels could pose a risk if market conditions deteriorate or interest rates rise, impacting financial stability. Strengths include a solid operational framework with effective cash flow management and a stable shareholder base, while risks encompass reliance on debt, fluctuating sales, and low profitability margins. In scenarios where the company can improve its operating profit margins and manage debt effectively, it may strengthen its market position. Conversely, failure to enhance profitability or manage costs could lead to further declines in investor confidence and financial performance.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Advance Petrochemicals Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Fischer Medical Ventures Ltd | 6,054 Cr. | 91.8 | 125/60.0 | 301 | 5.29 | 0.01 % | 1.08 % | 0.70 % | 1.00 |
| Emmessar Biotech & Nutrition Ltd | 15.0 Cr. | 30.0 | 54.7/25.8 | 37.5 | 15.4 | 0.00 % | 12.6 % | 4.23 % | 10.0 |
| Cochin Minerals & Rutile Ltd | 213 Cr. | 272 | 410/238 | 12.7 | 211 | 2.95 % | 23.3 % | 15.0 % | 10.0 |
| Archean Chemical Industries Ltd | 7,804 Cr. | 630 | 730/408 | 35.4 | 152 | 0.48 % | 16.0 % | 12.0 % | 2.00 |
| Alufluoride Ltd | 358 Cr. | 458 | 544/376 | 17.5 | 144 | 0.65 % | 23.6 % | 20.8 % | 10.0 |
| Industry Average | 5,537.25 Cr | 563.89 | 147.11 | 154.12 | 0.48% | 13.95% | 10.65% | 7.00 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 9.83 | 9.28 | 10.01 | 7.97 | 8.21 | 8.19 | 7.80 | 10.99 | 10.80 | 11.25 | 12.72 | 15.16 | 9.51 |
| Expenses | 8.94 | 8.23 | 9.34 | 7.82 | 8.13 | 7.40 | 7.45 | 10.38 | 10.41 | 11.15 | 12.35 | 14.51 | 9.09 |
| Operating Profit | 0.89 | 1.05 | 0.67 | 0.15 | 0.08 | 0.79 | 0.35 | 0.61 | 0.39 | 0.10 | 0.37 | 0.65 | 0.42 |
| OPM % | 9.05% | 11.31% | 6.69% | 1.88% | 0.97% | 9.65% | 4.49% | 5.55% | 3.61% | 0.89% | 2.91% | 4.29% | 4.42% |
| Other Income | 0.00 | 0.07 | 0.05 | -0.03 | 0.01 | 0.00 | 0.01 | 0.03 | 0.02 | 0.34 | 0.01 | 0.04 | 0.02 |
| Interest | 0.19 | 0.19 | 0.18 | 0.18 | 0.20 | 0.21 | 0.21 | 0.23 | 0.22 | 0.25 | 0.20 | 0.18 | 0.27 |
| Depreciation | 0.12 | 0.12 | 0.12 | 0.43 | 0.20 | 0.20 | 0.20 | 0.10 | 0.17 | 0.17 | 0.17 | 0.08 | 0.15 |
| Profit before tax | 0.58 | 0.81 | 0.42 | -0.49 | -0.31 | 0.38 | -0.05 | 0.31 | 0.02 | 0.02 | 0.01 | 0.43 | 0.02 |
| Tax % | 0.00% | 43.21% | 23.81% | -16.33% | 0.00% | 5.26% | 0.00% | 25.81% | 0.00% | 0.00% | 100.00% | 39.53% | 0.00% |
| Net Profit | 0.58 | 0.46 | 0.31 | -0.41 | -0.31 | 0.37 | -0.05 | 0.23 | 0.01 | 0.02 | 0.00 | 0.27 | 0.01 |
| EPS in Rs | 6.44 | 5.11 | 3.44 | -4.56 | -3.44 | 4.11 | -0.56 | 2.56 | 0.11 | 0.22 | 0.00 | 3.00 | 0.11 |
Last Updated: August 20, 2025, 12:25 am
Below is a detailed analysis of the quarterly data for Advance Petrochemicals Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 9.51 Cr.. The value appears to be declining and may need further review. It has decreased from 15.16 Cr. (Mar 2025) to 9.51 Cr., marking a decrease of 5.65 Cr..
- For Expenses, as of Jun 2025, the value is 9.09 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 14.51 Cr. (Mar 2025) to 9.09 Cr., marking a decrease of 5.42 Cr..
- For Operating Profit, as of Jun 2025, the value is 0.42 Cr.. The value appears to be declining and may need further review. It has decreased from 0.65 Cr. (Mar 2025) to 0.42 Cr., marking a decrease of 0.23 Cr..
- For OPM %, as of Jun 2025, the value is 4.42%. The value appears strong and on an upward trend. It has increased from 4.29% (Mar 2025) to 4.42%, marking an increase of 0.13%.
- For Other Income, as of Jun 2025, the value is 0.02 Cr.. The value appears to be declining and may need further review. It has decreased from 0.04 Cr. (Mar 2025) to 0.02 Cr., marking a decrease of 0.02 Cr..
- For Interest, as of Jun 2025, the value is 0.27 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.18 Cr. (Mar 2025) to 0.27 Cr., marking an increase of 0.09 Cr..
- For Depreciation, as of Jun 2025, the value is 0.15 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.08 Cr. (Mar 2025) to 0.15 Cr., marking an increase of 0.07 Cr..
- For Profit before tax, as of Jun 2025, the value is 0.02 Cr.. The value appears to be declining and may need further review. It has decreased from 0.43 Cr. (Mar 2025) to 0.02 Cr., marking a decrease of 0.41 Cr..
- For Tax %, as of Jun 2025, the value is 0.00%. The value appears to be improving (decreasing) as expected. It has decreased from 39.53% (Mar 2025) to 0.00%, marking a decrease of 39.53%.
- For Net Profit, as of Jun 2025, the value is 0.01 Cr.. The value appears to be declining and may need further review. It has decreased from 0.27 Cr. (Mar 2025) to 0.01 Cr., marking a decrease of 0.26 Cr..
- For EPS in Rs, as of Jun 2025, the value is 0.11. The value appears to be declining and may need further review. It has decreased from 3.00 (Mar 2025) to 0.11, marking a decrease of 2.89.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 4:02 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 12.54 | 11.20 | 10.46 | 8.85 | 12.74 | 21.29 | 13.90 | 17.44 | 27.92 | 37.09 | 35.19 | 49.94 | 48.64 |
| Expenses | 12.00 | 10.42 | 9.62 | 7.97 | 11.90 | 20.31 | 12.99 | 16.25 | 26.42 | 34.33 | 33.36 | 48.43 | 47.10 |
| Operating Profit | 0.54 | 0.78 | 0.84 | 0.88 | 0.84 | 0.98 | 0.91 | 1.19 | 1.50 | 2.76 | 1.83 | 1.51 | 1.54 |
| OPM % | 4.31% | 6.96% | 8.03% | 9.94% | 6.59% | 4.60% | 6.55% | 6.82% | 5.37% | 7.44% | 5.20% | 3.02% | 3.17% |
| Other Income | 0.18 | 0.01 | 0.03 | 0.03 | 0.08 | 0.09 | 0.10 | 0.12 | 0.06 | 0.09 | 0.06 | 0.41 | 0.41 |
| Interest | 0.40 | 0.45 | 0.53 | 0.58 | 0.64 | 0.77 | 0.77 | 0.72 | 0.72 | 0.74 | 0.88 | 0.85 | 0.90 |
| Depreciation | 0.13 | 0.20 | 0.19 | 0.18 | 0.18 | 0.19 | 0.17 | 0.22 | 0.40 | 0.79 | 0.70 | 0.60 | 0.57 |
| Profit before tax | 0.19 | 0.14 | 0.15 | 0.15 | 0.10 | 0.11 | 0.07 | 0.37 | 0.44 | 1.32 | 0.31 | 0.47 | 0.48 |
| Tax % | 36.84% | 64.29% | 53.33% | 46.67% | 10.00% | 0.00% | 0.00% | 27.03% | 31.82% | 28.03% | 32.26% | 36.17% | |
| Net Profit | 0.12 | 0.06 | 0.07 | 0.09 | 0.08 | 0.11 | 0.07 | 0.28 | 0.30 | 0.94 | 0.22 | 0.30 | 0.30 |
| EPS in Rs | 1.33 | 0.67 | 0.78 | 1.00 | 0.89 | 1.22 | 0.78 | 3.11 | 3.33 | 10.44 | 2.44 | 3.33 | 3.33 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -50.00% | 16.67% | 28.57% | -11.11% | 37.50% | -36.36% | 300.00% | 7.14% | 213.33% | -76.60% | 36.36% |
| Change in YoY Net Profit Growth (%) | 0.00% | 66.67% | 11.90% | -39.68% | 48.61% | -73.86% | 336.36% | -292.86% | 206.19% | -289.93% | 112.96% |
Advance Petrochemicals Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 16% |
| 5 Years: | 29% |
| 3 Years: | 21% |
| TTM: | 29% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 17% |
| 5 Years: | 34% |
| 3 Years: | -4% |
| TTM: | -46% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | 37% |
| 3 Years: | 27% |
| 1 Year: | -39% |
| Return on Equity | |
|---|---|
| 10 Years: | 10% |
| 5 Years: | 14% |
| 3 Years: | 14% |
| Last Year: | 8% |
Last Updated: September 5, 2025, 2:06 pm
No data available for the Balance Sheet data table.
Cash Flow - No data available for this post.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 61.71 | 73.98 | 80.26 | 51.97 | 53.00 | 41.83 | 32.30 | 53.16 | 63.93 | 35.92 | 93.56 | 70.97 |
| Inventory Days | 77.37 | 118.64 | 135.92 | 271.87 | 226.41 | 127.25 | 217.07 | 185.97 | 111.70 | 76.07 | 89.34 | 53.73 |
| Days Payable | 38.87 | 49.55 | 34.11 | 98.61 | 89.06 | 61.39 | 56.50 | 75.02 | 100.40 | 57.52 | 131.91 | 87.28 |
| Cash Conversion Cycle | 100.21 | 143.07 | 182.07 | 225.22 | 190.35 | 107.69 | 192.87 | 164.11 | 75.23 | 54.46 | 50.98 | 37.41 |
| Working Capital Days | 25.32 | 22.81 | 20.24 | 29.69 | 25.78 | 11.66 | 13.39 | 13.19 | 3.53 | -5.90 | 0.93 | -2.12 |
| ROCE % | 11.52% | 10.88% | 10.62% | 10.70% | 9.97% | 10.73% | 9.92% | 11.82% | 12.61% | 20.35% | 10.16% | 9.56% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 3.36 | 2.40 | 10.49 | 3.28 | 3.09 |
| Diluted EPS (Rs.) | 3.36 | 2.40 | 10.49 | 3.28 | 3.09 |
| Cash EPS (Rs.) | 10.00 | 10.12 | 19.28 | 7.75 | 5.51 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 44.86 | 40.43 | 38.03 | 27.54 | 24.25 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 44.86 | 41.50 | 39.10 | 28.61 | 25.32 |
| Revenue From Operations / Share (Rs.) | 554.84 | 390.97 | 412.12 | 310.20 | 193.80 |
| PBDIT / Share (Rs.) | 21.39 | 20.96 | 31.64 | 17.29 | 14.57 |
| PBIT / Share (Rs.) | 14.75 | 13.24 | 22.85 | 12.82 | 12.15 |
| PBT / Share (Rs.) | 5.28 | 3.48 | 14.62 | 4.84 | 4.17 |
| Net Profit / Share (Rs.) | 3.36 | 2.40 | 10.49 | 3.28 | 3.09 |
| PBDIT Margin (%) | 3.85 | 5.36 | 7.67 | 5.57 | 7.51 |
| PBIT Margin (%) | 2.65 | 3.38 | 5.54 | 4.13 | 6.26 |
| PBT Margin (%) | 0.95 | 0.88 | 3.54 | 1.56 | 2.15 |
| Net Profit Margin (%) | 0.60 | 0.61 | 2.54 | 1.05 | 1.59 |
| Return on Networth / Equity (%) | 7.48 | 5.93 | 27.59 | 11.92 | 12.76 |
| Return on Capital Employeed (%) | 15.20 | 16.84 | 35.07 | 24.49 | 21.89 |
| Return On Assets (%) | 1.19 | 0.95 | 6.00 | 1.91 | 2.17 |
| Long Term Debt / Equity (X) | 1.07 | 0.82 | 0.59 | 0.73 | 1.12 |
| Total Debt / Equity (X) | 2.69 | 2.47 | 2.10 | 2.75 | 3.36 |
| Asset Turnover Ratio (%) | 2.08 | 1.83 | 2.38 | 1.98 | 1.48 |
| Current Ratio (X) | 1.02 | 1.05 | 0.98 | 1.07 | 1.17 |
| Quick Ratio (X) | 0.67 | 0.65 | 0.45 | 0.52 | 0.40 |
| Inventory Turnover Ratio (X) | 6.56 | 4.65 | 4.37 | 3.22 | 2.10 |
| Interest Coverage Ratio (X) | 2.26 | 2.15 | 3.85 | 2.17 | 1.83 |
| Interest Coverage Ratio (Post Tax) (X) | 1.35 | 1.25 | 2.28 | 1.41 | 1.39 |
| Enterprise Value (Cr.) | 28.04 | 25.00 | 48.28 | 10.15 | 10.42 |
| EV / Net Operating Revenue (X) | 0.56 | 0.71 | 1.30 | 0.36 | 0.59 |
| EV / EBITDA (X) | 14.56 | 13.25 | 16.96 | 6.52 | 7.95 |
| MarketCap / Net Operating Revenue (X) | 0.35 | 0.47 | 1.12 | 0.13 | 0.19 |
| Price / BV (X) | 4.43 | 4.58 | 12.15 | 1.52 | 1.59 |
| Price / Net Operating Revenue (X) | 0.35 | 0.47 | 1.12 | 0.13 | 0.19 |
| EarningsYield | 0.01 | 0.01 | 0.02 | 0.07 | 0.08 |
After reviewing the key financial ratios for Advance Petrochemicals Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 3.36. This value is below the healthy minimum of 5. It has increased from 2.40 (Mar 24) to 3.36, marking an increase of 0.96.
- For Diluted EPS (Rs.), as of Mar 25, the value is 3.36. This value is below the healthy minimum of 5. It has increased from 2.40 (Mar 24) to 3.36, marking an increase of 0.96.
- For Cash EPS (Rs.), as of Mar 25, the value is 10.00. This value is within the healthy range. It has decreased from 10.12 (Mar 24) to 10.00, marking a decrease of 0.12.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 44.86. It has increased from 40.43 (Mar 24) to 44.86, marking an increase of 4.43.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 44.86. It has increased from 41.50 (Mar 24) to 44.86, marking an increase of 3.36.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 554.84. It has increased from 390.97 (Mar 24) to 554.84, marking an increase of 163.87.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 21.39. This value is within the healthy range. It has increased from 20.96 (Mar 24) to 21.39, marking an increase of 0.43.
- For PBIT / Share (Rs.), as of Mar 25, the value is 14.75. This value is within the healthy range. It has increased from 13.24 (Mar 24) to 14.75, marking an increase of 1.51.
- For PBT / Share (Rs.), as of Mar 25, the value is 5.28. This value is within the healthy range. It has increased from 3.48 (Mar 24) to 5.28, marking an increase of 1.80.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 3.36. This value is within the healthy range. It has increased from 2.40 (Mar 24) to 3.36, marking an increase of 0.96.
- For PBDIT Margin (%), as of Mar 25, the value is 3.85. This value is below the healthy minimum of 10. It has decreased from 5.36 (Mar 24) to 3.85, marking a decrease of 1.51.
- For PBIT Margin (%), as of Mar 25, the value is 2.65. This value is below the healthy minimum of 10. It has decreased from 3.38 (Mar 24) to 2.65, marking a decrease of 0.73.
- For PBT Margin (%), as of Mar 25, the value is 0.95. This value is below the healthy minimum of 10. It has increased from 0.88 (Mar 24) to 0.95, marking an increase of 0.07.
- For Net Profit Margin (%), as of Mar 25, the value is 0.60. This value is below the healthy minimum of 5. It has decreased from 0.61 (Mar 24) to 0.60, marking a decrease of 0.01.
- For Return on Networth / Equity (%), as of Mar 25, the value is 7.48. This value is below the healthy minimum of 15. It has increased from 5.93 (Mar 24) to 7.48, marking an increase of 1.55.
- For Return on Capital Employeed (%), as of Mar 25, the value is 15.20. This value is within the healthy range. It has decreased from 16.84 (Mar 24) to 15.20, marking a decrease of 1.64.
- For Return On Assets (%), as of Mar 25, the value is 1.19. This value is below the healthy minimum of 5. It has increased from 0.95 (Mar 24) to 1.19, marking an increase of 0.24.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 1.07. This value exceeds the healthy maximum of 1. It has increased from 0.82 (Mar 24) to 1.07, marking an increase of 0.25.
- For Total Debt / Equity (X), as of Mar 25, the value is 2.69. This value exceeds the healthy maximum of 1. It has increased from 2.47 (Mar 24) to 2.69, marking an increase of 0.22.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 2.08. It has increased from 1.83 (Mar 24) to 2.08, marking an increase of 0.25.
- For Current Ratio (X), as of Mar 25, the value is 1.02. This value is below the healthy minimum of 1.5. It has decreased from 1.05 (Mar 24) to 1.02, marking a decrease of 0.03.
- For Quick Ratio (X), as of Mar 25, the value is 0.67. This value is below the healthy minimum of 1. It has increased from 0.65 (Mar 24) to 0.67, marking an increase of 0.02.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 6.56. This value is within the healthy range. It has increased from 4.65 (Mar 24) to 6.56, marking an increase of 1.91.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 2.26. This value is below the healthy minimum of 3. It has increased from 2.15 (Mar 24) to 2.26, marking an increase of 0.11.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 1.35. This value is below the healthy minimum of 3. It has increased from 1.25 (Mar 24) to 1.35, marking an increase of 0.10.
- For Enterprise Value (Cr.), as of Mar 25, the value is 28.04. It has increased from 25.00 (Mar 24) to 28.04, marking an increase of 3.04.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.56. This value is below the healthy minimum of 1. It has decreased from 0.71 (Mar 24) to 0.56, marking a decrease of 0.15.
- For EV / EBITDA (X), as of Mar 25, the value is 14.56. This value is within the healthy range. It has increased from 13.25 (Mar 24) to 14.56, marking an increase of 1.31.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.35. This value is below the healthy minimum of 1. It has decreased from 0.47 (Mar 24) to 0.35, marking a decrease of 0.12.
- For Price / BV (X), as of Mar 25, the value is 4.43. This value exceeds the healthy maximum of 3. It has decreased from 4.58 (Mar 24) to 4.43, marking a decrease of 0.15.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.35. This value is below the healthy minimum of 1. It has decreased from 0.47 (Mar 24) to 0.35, marking a decrease of 0.12.
- For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
Unable to fetch valid data for stock valuation.Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Advance Petrochemicals Ltd:
- Net Profit Margin: 0.6%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 15.2% (Industry Average ROCE: 13.95%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 7.48% (Industry Average ROE: 10.65%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 1.35
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.67
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 408 (Industry average Stock P/E: 147.11)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 2.69
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 0.6%